Investigational gene therapy trial for rare kidney disease begins clinical trial at UAB
March 17, 2026
March 17, 2026
BIRMINGHAM, Alabama, March 17 -- The University of Alabama issued the following news:
* * *
Investigational gene therapy trial for rare kidney disease begins clinical trial at UAB
*
Eric Wallace, M.D. The University of Alabama at Birmingham is taking part in a groundbreaking Phase I/II clinical trial testing a one-time, intravenous investigational gene therapy that could transform care for patients with classic Fabry disease.
Fabr . . .
* * *
Investigational gene therapy trial for rare kidney disease begins clinical trial at UAB
*
Eric Wallace, M.D. The University of Alabama at Birmingham is taking part in a groundbreaking Phase I/II clinical trial testing a one-time, intravenous investigational gene therapy that could transform care for patients with classic Fabry disease.
Fabr . . .